A recent CNN article discussed a new study that suggests a type of cell therapy could potentially improve the heart function of patients with heart failure. The study involved 60 patients with heart failure who received either a placebo or an injection of cardiosphere-derived cells, a type of cell therapy derived from a patient's own heart tissue. After six months, patients who received the cell therapy showed an average improvement of 10% in their heart's ability to pump blood, while those in the placebo group showed no improvement. The cell therapy was also found to be safe and well-tolerated, with no serious adverse events reported.
Cell Therapy Shows Promise in Heart Failure Patients
A new study showed that heart failure patients who received cell therapy saw improved heart function, exercise capacity, and quality of life.
Mar 10, 2023
Texas Heart Institute
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!Unlock Learning Here
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!Take Quiz